ProThera Revenue and Competitors

Reno, NV USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • ProThera's estimated annual revenue is currently $6.5M per year.(i)
  • ProThera's estimated revenue per employee is $216,000

Employee Data

  • ProThera has 30 Employees.(i)
  • ProThera grew their employee count by 3% last year.

ProThera's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46M15511%N/AN/A
#2
$267.6M708-3%N/AN/A
#3
$4.5M24-11%N/AN/A
#4
$0.3M2-60%N/AN/A
#5
$5.5M290%N/AN/A
#6
$10.2M474%N/AN/A
#7
$9.7M45-10%N/AN/A
#8
$128.6M3818%N/AN/A
#9
$20.8M77-6%N/AN/A
#10
$7.6M35-27%N/AN/A
Add Company

What Is ProThera?

ProThera, Inc. manufactures a comprehensive line of nutraceutical products for exclusive distribution by healthcare professionals. Products are designed for medical applications based on 50 years of combined formulation experience by the company's founders, Dennis Meiss, Ph.D. and Janet Ralston, B.S., working in close association with an advisory board of medical consultants with extensive clinical experience in nutritional medicine. A coordinated group of multinutrient products with focused clinical applications forms the core of the ProThera product line with special emphasis given to avoiding nutrient redundancy, maintaining cost-effectiveness, and encouraging patient compliance. Flexibility, rapid-response times, and personalized attention to the individual needs of healthcare professionals describe ProThera's underlying service philosophy.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$6.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ProThera News

2022-04-17 - Le marché des ménaquinones connaît une croissance énorme pour ...

GeneFerm Biotechnology, ProThera, DuPont Nutrition & Health, Natural Factors, Blackmores, DSM, Kappa Bioscience, Gnosis, NattoPharma,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5M307%N/A
#2
$3.5M303%N/A
#3
$4M300%N/A
#4
$5.9M300%N/A
#5
$5M303%N/A